Worldwide Index of Serotype-Specific Pneumococcal Antibody Responses (WISSPAR): A curated database of clinical trial data

Gates Open Research

article

Stephanie Perniciaro¹  Dominic Cooper-Wooton¹  Maria Knoll²  Daniel Weinberger¹ 

[1] Epidemiology of Microbial Diseases, Yale University;International Vaccine Access Center, Department of International Health, Johns Hopkins University

关键词: clinical trials;    pneumococcal disease;    pneumococcal conjugate vaccines;    immunogenicity;    Streptococcus pneumoniae;   

DOI  :  10.12688/gatesopenres.14768.1

学科分类：电子与电气工程

来源: American Journal Of Pharmtech Research

【 摘 要 】

The Worldwide Index of Serotype Specific Pneumococcal Antibody Responses (WISSPAR; https://wisspar.com), is a centralized, online platform housing data on immunogenicity from clinical trials of pneumococcal vaccines. The data on WISSPAR are primarily curated from outcomes tables from clinical trials and are made available in a searchable format that can be readily used for downstream analyses. The WISSPAR database includes trials covering numerous vaccine products, manufacturers, dosing schedules, age groups, immunocompromised groups, and geographic regions. Customizable data visualization tools are embedded within the site, or the data can be exported for further analyses. Users can also browse summary information about the clinical trials and their results. WISSPAR provides a platform for analysts and policy makers to efficiently gather, compare, and collate clinical trial data about pneumococcal vaccines.

【 授权许可】

CC BY